Literature DB >> 22125075

Exploring functional in vivo consequences of the selective genetic ablation of mTOR signaling in T helper lymphocytes.

Greg M Delgoffe1, Jonathan D Powell.   

Abstract

The mammalian Target of Rapamycin (mTOR) defines a crucial link between nutrient sensing and immune function. In CD4+ T cells, mTOR has been shown to play a critical role in regulating effector and regulatory T cell differentiation as well as the decision between full activation versus the induction of anergy. In this chapter, we describe how our group has employed the Cre-lox technology to genetically delete components of the mTOR signaling complex in T cells. This has enabled us to specifically interrogate mTOR function in T cells both in vitro and in vivo. We also describe techniques used to assay immune function and signaling in mTOR-deficient T cells at the single-cell level.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22125075      PMCID: PMC3571700          DOI: 10.1007/978-1-61779-430-8_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

1.  The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment.

Authors:  Greg M Delgoffe; Thomas P Kole; Yan Zheng; Paul E Zarek; Krystal L Matthews; Bo Xiao; Paul F Worley; Sara C Kozma; Jonathan D Powell
Journal:  Immunity       Date:  2009-06-19       Impact factor: 31.745

2.  Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells.

Authors:  Danila Valmori; Valeria Tosello; Naira E Souleimanian; Emmanuelle Godefroy; Luigi Scotto; Yu Wang; Maha Ayyoub
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

Review 3.  mTOR and cancer: insights into a complex relationship.

Authors:  David M Sabatini
Journal:  Nat Rev Cancer       Date:  2006-08-17       Impact factor: 60.716

4.  Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells.

Authors:  Heather Kopf; Gonzalo M de la Rosa; O M Zack Howard; Xin Chen
Journal:  Int Immunopharmacol       Date:  2007-09-20       Impact factor: 4.932

5.  The pharmacology of mTOR inhibition.

Authors:  David A Guertin; David M Sabatini
Journal:  Sci Signal       Date:  2009-04-21       Impact factor: 8.192

6.  Anergic T cells are metabolically anergic.

Authors:  Yan Zheng; Greg M Delgoffe; Christian F Meyer; Waipan Chan; Jonathan D Powell
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

7.  The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin.

Authors:  Rajesh R Rao; Qingsheng Li; Kunle Odunsi; Protul A Shrikant
Journal:  Immunity       Date:  2010-01-07       Impact factor: 31.745

Review 8.  Defining the role of mTOR in cancer.

Authors:  David A Guertin; David M Sabatini
Journal:  Cancer Cell       Date:  2007-07       Impact factor: 31.743

9.  mTOR regulates memory CD8 T-cell differentiation.

Authors:  Koichi Araki; Alexandra P Turner; Virginia Oliva Shaffer; Shivaprakash Gangappa; Susanne A Keller; Martin F Bachmann; Christian P Larsen; Rafi Ahmed
Journal:  Nature       Date:  2009-06-21       Impact factor: 49.962

10.  Nogo-66 promotes the differentiation of neural progenitors into astroglial lineage cells through mTOR-STAT3 pathway.

Authors:  Bin Wang; Zhifeng Xiao; Bing Chen; Jin Han; Yuan Gao; Jing Zhang; Wenxue Zhao; Xia Wang; Jianwu Dai
Journal:  PLoS One       Date:  2008-03-26       Impact factor: 3.240

View more
  3 in total

Review 1.  Age-Related Neurodegeneration Prevention Through mTOR Inhibition: Potential Mechanisms and Remaining Questions.

Authors:  Jordan B Jahrling; Remi-Martin Laberge
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

2.  Effects of rapamycin combined with low dose prednisone in patients with chronic immune thrombocytopenia.

Authors:  Jiaming Li; Zhaoyue Wang; Lan Dai; Lijuan Cao; Jian Su; Mingqing Zhu; Ziqiang Yu; Xia Bai; Changgeng Ruan
Journal:  Clin Dev Immunol       Date:  2013-12-02

Review 3.  The role of mechanistic target of rapamycin (mTOR) complexes signaling in the immune responses.

Authors:  Ghada A Soliman
Journal:  Nutrients       Date:  2013-06-19       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.